Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)
EUR 60.35
(0.58%)
EUR 60.35
(0.58%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 57.48 Million EUR | 6.49% |
| 2022 | 56.7 Million EUR | 19.77% |
| 2021 | 56.68 Million EUR | 2.59% |
| 2020 | 42.31 Million EUR | 2.34% |
| 2019 | 42.93 Million EUR | 40.47% |
| 2018 | 31.95 Million EUR | 23.34% |
| 2017 | 26.49 Million EUR | 2.88% |
| 2016 | 23.67 Million EUR | -2.69% |
| 2015 | 27.14 Million EUR | 27.23% |
| 2014 | 20.82 Million EUR | -0.07% |
| 2013 | 20.54 Million EUR | -26.37% |
| 2012 | 26.26 Million EUR | -8.44% |
| 2011 | 29.41 Million EUR | 14.25% |
| 2010 | 25.41 Million EUR | -1.43% |
| 2009 | 23.6 Million EUR | 44.75% |
| 2008 | 15.4 Million EUR | -52.58% |
| 2007 | 9.48 Million EUR | 7.2% |
| 2006 | 10.15 Million EUR | 470.29% |
| 2005 | 6.44 Million EUR | -10.33% |
| 2004 | 7.19 Million EUR | 22.28% |
| 2003 | 5.88 Million EUR | -5.96% |
| 2002 | 6.25 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 20.4 Million EUR | 4.55% |
| 2024 Q2 | 27 Million EUR | 13.67% |
| 2024 Q3 | 15.5 Million EUR | -23.49% |
| 2023 FY | - EUR | 6.49% |
| 2023 Q4 | 17 Million EUR | 2.87% |
| 2023 Q3 | 16.52 Million EUR | 10.49% |
| 2023 Q2 | 14.95 Million EUR | 28.54% |
| 2023 Q1 | 11.63 Million EUR | -2.04% |
| 2022 Q1 | 12.71 Million EUR | 2834.19% |
| 2022 FY | - EUR | 19.77% |
| 2022 Q4 | 11.87 Million EUR | -24.12% |
| 2022 Q2 | 16.67 Million EUR | 31.12% |
| 2022 Q3 | 15.65 Million EUR | -6.09% |
| 2021 FY | - EUR | 2.59% |
| 2021 Q1 | 23.08 Million EUR | 133.46% |
| 2021 Q2 | 11.54 Million EUR | -49.99% |
| 2021 Q3 | 13.35 Million EUR | 15.67% |
| 2021 Q4 | -465 Thousand EUR | -103.48% |
| 2020 Q3 | 10.8 Million EUR | -17.46% |
| 2020 FY | - EUR | 2.34% |
| 2020 Q1 | 11.12 Million EUR | 67.95% |
| 2020 Q4 | 9.88 Million EUR | -8.46% |
| 2020 Q2 | 13.08 Million EUR | 17.66% |
| 2019 Q3 | 11.8 Million EUR | -11.45% |
| 2019 Q2 | 13.33 Million EUR | 14.35% |
| 2019 Q1 | 11.66 Million EUR | 63.63% |
| 2019 FY | - EUR | 40.47% |
| 2019 Q4 | 6.62 Million EUR | -43.92% |
| 2018 Q2 | 11.04 Million EUR | 84.11% |
| 2018 FY | - EUR | 23.34% |
| 2018 Q4 | 7.12 Million EUR | -10.5% |
| 2018 Q1 | 5.99 Million EUR | 2.76% |
| 2018 Q3 | 7.96 Million EUR | -27.91% |
| 2017 Q1 | 7.67 Million EUR | 28.72% |
| 2017 FY | - EUR | 2.88% |
| 2017 Q4 | 5.83 Million EUR | -11.6% |
| 2017 Q3 | 6.6 Million EUR | -2.16% |
| 2017 Q2 | 6.75 Million EUR | -12.08% |
| 2016 FY | - EUR | -2.69% |
| 2016 Q2 | 6.88 Million EUR | 8.65% |
| 2016 Q3 | 6.15 Million EUR | -10.55% |
| 2016 Q1 | 6.33 Million EUR | 1.2% |
| 2016 Q4 | 5.96 Million EUR | -3.13% |
| 2015 Q3 | 4.17 Million EUR | -53.2% |
| 2015 FY | - EUR | 27.23% |
| 2015 Q4 | 6.26 Million EUR | 50.01% |
| 2015 Q2 | 8.91 Million EUR | 31.81% |
| 2015 Q1 | 6.76 Million EUR | 35.87% |
| 2014 Q2 | 5.04 Million EUR | 5.48% |
| 2014 Q1 | 4.78 Million EUR | -27.6% |
| 2014 FY | - EUR | -0.07% |
| 2014 Q3 | 5.71 Million EUR | 13.24% |
| 2014 Q4 | 4.97 Million EUR | -12.88% |
| 2013 FY | - EUR | -26.37% |
| 2013 Q1 | 4.28 Million EUR | -47.32% |
| 2013 Q2 | 6.11 Million EUR | 42.76% |
| 2013 Q3 | 6.37 Million EUR | 4.17% |
| 2013 Q4 | 6.6 Million EUR | 3.74% |
| 2012 FY | - EUR | -8.44% |
| 2012 Q1 | 7.16 Million EUR | -9.56% |
| 2012 Q3 | 5.99 Million EUR | -14.13% |
| 2012 Q4 | 8.13 Million EUR | 35.6% |
| 2012 Q2 | 6.98 Million EUR | -2.47% |
| 2011 Q4 | 7.91 Million EUR | 18.29% |
| 2011 FY | - EUR | 14.25% |
| 2011 Q3 | 6.69 Million EUR | -9.33% |
| 2011 Q2 | 7.38 Million EUR | -12.86% |
| 2011 Q1 | 8.47 Million EUR | 57.11% |
| 2010 Q4 | 5.39 Million EUR | -31.77% |
| 2010 FY | - EUR | -1.43% |
| 2010 Q1 | 6.97 Million EUR | -36.55% |
| 2010 Q2 | 6.4 Million EUR | -8.15% |
| 2010 Q3 | 7.9 Million EUR | 23.46% |
| 2009 Q2 | 6.08 Million EUR | 19.62% |
| 2009 Q1 | 5.08 Million EUR | 0.0% |
| 2009 FY | - EUR | 44.75% |
| 2009 Q4 | 10.98 Million EUR | 124.09% |
| 2009 Q3 | 4.9 Million EUR | -19.43% |
| 2008 FY | - EUR | -52.58% |
| 2007 FY | - EUR | 7.2% |
| 2006 FY | - EUR | 470.29% |
| 2005 FY | - EUR | -10.33% |
| 2004 FY | - EUR | 22.28% |
| 2003 FY | - EUR | -5.96% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| aap Implantate AG | -3.43 Million EUR | 1775.087% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 81.941% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 81.941% |
| elexxion AG | -860.59 Thousand EUR | 6780.115% |
| Geratherm Medical AG | 4.18 Million EUR | -1273.894% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 94.478% |
| Stratec SE | 39.82 Million EUR | -44.369% |
| Siemens Healthineers AG | 4.22 Billion EUR | 98.639% |